Revenio Group has been granted a patent for an alignment means in measurement instruments. The invention features a housing, optical component, and multiple light sources, designed to control visibility along a principal axis, enhancing user alignment and measurement accuracy. GlobalData’s report on Revenio Group gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Revenio Group, was a key innovation area identified from patents. Revenio Group's grant share as of June 2024 was 54%. Grant share is based on the ratio of number of grants to total number of patents.
Measurement instrument alignment means with light sources and barriers
The granted patent US11980422B2 introduces an innovative alignment means for measurement instruments, particularly those used in ophthalmic applications. The alignment means consists of a housing that incorporates an optical component aligned with a principal axis, facilitating user alignment. It features multiple light sources positioned at varying distances and heights relative to the optical component, designed to enhance visibility and usability. The configuration includes an angle barrier that strategically blocks visibility of the light sources at specified distances, ensuring that users can focus on the measurement task without distraction. The patent also describes the potential for the light sources to emit differently colored light, blink, or take on various shapes, such as circular, enhancing the user experience.
Additionally, the patent outlines the structural components of the alignment means, including the arrangement of light emitters and light guides, with light-emitting diodes (LEDs) being a preferred choice. The angle barrier can take various forms, such as a disk or a supporting structure, and is positioned to optimize the alignment process. The patent further extends to measurement instruments that incorporate this alignment means, specifically targeting devices designed to measure intraocular pressure. These instruments may include a probe that can be ejected towards the eye, underscoring the practical applications of the alignment means in medical diagnostics. Overall, the patent presents a comprehensive solution aimed at improving the accuracy and efficiency of measurements in ophthalmic settings.
To know more about GlobalData’s detailed insights on Revenio Group, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.
